LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Spine/Spinal Elements Tests New LumbarSystem
Spine

Spinal Elements Tests New LumbarSystem

August 28, 2012 1 min read Premium comments

Advertisement

Spinal Elements Tests New LumbarSystem
Courtesy Spinal Elements, Inc.
Secondary

Hard on the heels of its just-released new product line Lucent Ti-Bond PEEK interbody implants, Spinal Elements Inc. announces completion of its first series of surgeries using its new Minimally Invasive Surgery (MIS) lumbar system. The system includes a series of towers that connect to the company’s Mercury Classic spinal system and other enabling instrumentation. This device allows the surgeon to deliver pedicle screws and rods in either percutaneous or mini-open procedures.

The development of the towers enables the Mercury Classic system, which has been successful and on the market since 2009, to be used in MIS procedures. Spine surgeon Douglas Musser, of Youngstown Orthopaedic Associates, said in the August 15 press release, “The fact that the Mercury Classic system has been designed to work well as a conventional or MIS system is very beneficial to me. No matter what my surgical plan, I know that the implant system will be the same.”

Todd Andres, CEO and co-founder of Spinal Elements, says that his firm has prepared an aggressive product launch schedule which will introduce “amazing solutions” to the spine market over the coming months. The company plans to introduce its first allograft product in October and has recently initiated clinical use of its Lotus Posterior Cervical/Thoracic System. Spinal Elements, Inc. is headquartered in Carlsbad, California.

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy